← board
NOTVQ
distress 2/10 · well-funded / low risk$0.010%today-100% from 52w high
Revenue
$239M
Liquidity
$15M
Runway
1.4 yrs
Shares 1y
+2%
Price & events
-98.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-1.8%
1W
-4.7%
1M
-96.3%
3M
-98.1%
6M
-99.5%
1Y
-99.5%
2Y
-100.0%
5Y
-99.9%
All
Overview
- Market Cap
- $387.26K
- Enterprise Value
- $-14.79M
- Volume
- 0
- 52 Week Range
- $0.01 – $2.36
- Total Shares
- 34.89M
- Float Shares
- 32.62M
- Short %
- 7.86%
- % Held by Insiders
- 8.63%
- % Held by Institutions
- 13.72%
- Beta
- 3.92
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-05earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2026-02-10Lake StreetBuy
Competitors
- none identified
Recent news
- 2026-07-21Inotiv Inc. (NOTV) Q2 2026 Earnings: Wider-Than-Expected Loss Stalls Share Performance - Profit Cycle Analysis - dars.gov.et
- 2026-07-16Inotiv, Inc. Announces Bankruptcy Proceedings and Restructuring Plan – Key Details from Form 8-K Filing 9 - Minichart
- 2026-07-11Inotiv Inc. (NOTV) Q2 2026 Earnings: EPS Misses Estimates Widely Amid Operational Challenges - Revenue Growth Report - dars.gov.et
- 2026-07-11Inotiv Inc. (NOTV) Q2 2026 Earnings: EPS Misses Estimates Widely Amid Operational Challenges - Earnings Beat Alert - Bölüm Sonu Canavarı
- 2026-06-23Inotiv Inc (NASDAQ: NOTV) Share Price, NOTV Stock News, NOTV Share Price & Updates - Kalkine
- 2026-06-18Inotiv Inc (NOTV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
- 2026-06-12NOTVQ Stock Price and Chart — OTC:NOTVQ - TradingView
- 2026-06-10Inotiv, Inc. Superpriority Secured Debtor-in-Possession Credit Agreement: Key Terms, Definitions, and Legal Framework (2026) – Minichart - Minichart
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.